Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
88.08
+4.34 (5.18%)
At close: Feb 21, 2025, 4:00 PM
88.01
-0.07 (-0.08%)
After-hours: Feb 21, 2025, 7:32 PM EST
Novo Nordisk Revenue by Segment
History
| Date | Diabetes | Obesity | Rare Disease |
|---|---|---|---|
| Dec 31, 2024 | 28.71B | 9.05B | 2.59B |
| Sep 30, 2024 | 27.52B | 7.64B | 2.43B |
| Jun 30, 2024 | 26.78B | 6.73B | 2.34B |
| Mar 31, 2024 | 25.35B | 6.23B | 2.36B |
| Dec 31, 2023 | 24.10B | 5.78B | 2.38B |
| Sep 30, 2023 | 22.39B | 4.99B | 2.42B |
| Jun 30, 2023 | 21.49B | 3.89B | 2.59B |
| Mar 31, 2023 | 20.46B | 2.96B | 2.74B |
| Dec 31, 2022 | 19.39B | 2.34B | 2.85B |
| Sep 30, 2022 | 18.47B | 1.92B | 2.83B |
| Jun 30, 2022 | 17.44B | 1.65B | 2.75B |
| Mar 31, 2022 | 16.56B | 1.42B | 2.72B |
| Dec 31, 2021 | 15.73B | 1.17B | 2.67B |
| Sep 30, 2021 | 14.68B | 993.66M | 2.63B |
| Jun 30, 2021 | 13.99B | 863.62M | 2.68B |
| Mar 31, 2021 | 13.71B | 787.21M | 2.65B |
| Dec 31, 2020 | 13.50B | 789.01M | 2.66B |
| Sep 30, 2020 | 13.97B | 839.86M | 2.78B |
| Jun 30, 2020 | 14.00B | 818.47M | 2.76B |
| Mar 31, 2020 | 14.14B | 804.02M | 2.73B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.